Imatinib resistant BCR-ABL1 mutations at relapse in children with Ph +ALL: A Children's Oncology Group (COG) study

Bill H. Chang, Stephanie G. Willis, Linda Stork, Stephen P. Hunger, William L. Carroll, Bruce M. Camitta, Naomi J. Winick, Brian J. Druker, Kirk R. Schultz

Research output: Contribution to journalLetter

24 Scopus citations
Original languageEnglish (US)
Pages (from-to)507-510
Number of pages4
JournalBritish Journal of Haematology
Volume157
Issue number4
DOIs
StatePublished - May 1 2012

Keywords

  • BCR-ABL1
  • Childhood
  • Leukaemia
  • Mutations

ASJC Scopus subject areas

  • Hematology

Cite this

Chang, B. H., Willis, S. G., Stork, L., Hunger, S. P., Carroll, W. L., Camitta, B. M., Winick, N. J., Druker, B. J., & Schultz, K. R. (2012). Imatinib resistant BCR-ABL1 mutations at relapse in children with Ph +ALL: A Children's Oncology Group (COG) study. British Journal of Haematology, 157(4), 507-510. https://doi.org/10.1111/j.1365-2141.2012.09039.x